RxDoctor Payments Data

John Delgaudio, MD

Otolaryngic Allergy · Atlanta, GANPI 1104937861

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,384 of the $48,986 with a category attached, or 62.0%. Medtronic accounts for 91.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $27,306 and has fallen 96.8% since, to $881 in 2025.

$48,986in general payments, 2019–2025

Across 53 payments — averaging $924.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$45K
  • Stryker$2K
  • Regeneron Healthcare Solutions, Inc.$683
  • Intersect ENT, Inc.$360
  • Spirair, Inc.$285
  • Arrinex, Inc.$160
  • plus $335 from 3 others
$4,166in research payments, 2019–2025

Across 4 payments — averaging $1041.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$4K

What the payments were for

  • Consulting fees$14,73030%
  • Speaking & faculty fees$30,38462%
  • Travel & lodging$1580%
  • Food & beverage$3,7148%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)28$44,910
Stryker5$2,255
Regeneron Healthcare Solutions, Inc.10$683
Intersect ENT, Inc.5$360
Spirair, Inc.1$285
Arrinex, Inc.1$160
Sanofi1$150
Neurent Medical Limited1$99
KARL Storz Endoscopy-america1$85

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngic allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$103,265
Medicare patients
127
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate15$173

Paid to pharmacies, not to this prescriber.

Other otolaryngic allergy in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →